Opham Pharmaceutical Import Profile — Madagascar (DGFT 2022–2026)

Name: Opham Pharmaceutical Import Records from India — 2 Products, $289.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Opham — Pharmaceutical Importer Profile (2026) | 2 Products, $289.8K Trade | TransData Nexus

Opham

Pharmaceutical Importer · Madagascar · Advanced Diabetes Medications Focus · $289.8K Total Trade · DGFT Verified

Opham is a pharmaceutical importer based in Madagascar with a total trade value of $289.8K across 2 products in 2 therapeutic categories. Based on 27 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Opham sources from 10 verified Indian suppliers, with Cipla Limited accounting for 37.9% of imports.

Opham — Import Portfolio & Supplier Network

Opham import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Opham?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Cipla Limited	$2.8M	645	37.9%
Global Pharma Healthcare Private Limited	$1.3M	259	17.9%
Lincoln Pharmaceuticals Limited	$1.3M

What Formulations Does Opham Import?

Formulation	Value	Ships
Harmless medicine- prednisolone 5 MG TAB	$246.3K	8
Harmless medicine - amlodipine 10 MG TAB	$146.2K	8
Harmless medicine- roxithromycin 150 MG	$129.0K	8
Misoprost TAB 200 MCG (misoprostol	$115.7K	4
Cloxacillin capsules 500 MG total net weight - 1005.000 kgs / price per kg. 60.41791	$100.0K	2
Pill 72 tablets (levonorgestrel 0.75MG)	$88.9K	6
Cloxacillin capsules 500 MG total net	$79.2K	2
Zaart 50 tablets (losartan potassium	$77.8K	8
Amlopres -5 tablets (amlodipine	$75.9K	8
Misoprost TAB 200 MCG (misoprostol 200mcg) [5790(packs	$74.4K	2
Harmless medicine - calcium lactate	$74.3K	8
Harmless medicine- cetrizine 10 MG	$64.4K	8
Harmless medicine -albendazole 400 MG	$63.1K	8
Harmless medicine-prednisolone-5MG prednisolone 5 MG tablet unit-20x10's qty-21800.	$62.2K	2
Zaart 50 tablets (losartan potassium 50MG) [1296(packs	$60.1K	2

Opham imports 766 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Glibenclamide	Advanced Diabetes Medications	$181.8K	17	0.4%	3
2	Diazepam	CNS & Psychiatric	$108.0K	10	1.4%	11

Opham imports 2 pharmaceutical products across 2 categories into Madagascar totaling $289.8K.

Opham — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Opham, established in 1952 by Professor Ratsimanga, is a leading pharmaceutical wholesaler and distributor based in Antananarivo, Madagascar. The company specializes in the importation, distribution, and representation of pharmaceutical products, serving as a pivotal player in Madagascar's healthcare sector. Opham's extensive portfolio includes over 4,500 specialty and generic products, catering to pharmacies and hospitals nationwide.

The company operates under the leadership of CEO Gisèle Jeanne Yvette Cadillac, who has been instrumental in steering Opham's growth and maintaining its position as a market leader. (les-professionnels-de-madagascar.mg) Opham's commitment to quality is underscored by its ISO 9001 certification, ensuring adherence to international distribution standards. (opham.mg) This dedication to excellence has solidified Opham's reputation as a trusted partner for both local and international pharmaceutical manufacturers.

2Distribution Network

Opham's distribution network is strategically designed to ensure comprehensive coverage across Madagascar. The company's headquarters in Antananarivo serve as the central hub for operations, facilitating efficient logistics and coordination. While specific details about additional warehouse locations are not publicly disclosed, Opham's extensive reach indicates a well-established infrastructure capable of meeting the diverse needs of the Malagasy market. (opham.mg)

The company's logistics capabilities are robust, supporting the importation and distribution of a wide array of pharmaceutical products. Opham's partnerships with major international laboratories, such as Pierre Fabre, Sanofi, and Novartis, reflect its capacity to manage complex supply chains and deliver products efficiently throughout the country. (opham.mg)

3Industry Role

Opham plays a multifaceted role in Madagascar's pharmaceutical supply chain, functioning as a primary wholesaler, distributor, and importer. The company's extensive network and partnerships with international pharmaceutical manufacturers enable it to supply a diverse range of products to pharmacies, hospitals, and clinics across the nation. (opham.mg) Additionally, Opham's involvement in the registration and promotion of medical products underscores its comprehensive approach to pharmaceutical distribution. (opham.mg)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Opham

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Opham's sourcing strategy exhibits a notable concentration, with a significant portion of its pharmaceutical imports originating from India. Between 2022 and 2026, Opham imported finished pharmaceutical formulations totaling $290,000 USD from India, encompassing 27 shipments and 766 unique formulations. The top five products imported include Glibenclamide ($182,000 USD) and Diazepam ($108,000 USD), accounting for 62.7% and 37.3% of the total import value, respectively.

This concentration suggests a strategic choice to leverage India's competitive pricing and manufacturing capabilities. However, it also indicates a dependency on a limited number of suppliers, which could pose risks related to supply chain disruptions or regulatory changes in India. The stability of Opham's relationships with these suppliers is crucial for maintaining a consistent supply of essential medications.

2Supply Chain Resilience

Opham's supply chain resilience is influenced by its concentrated sourcing from Indian suppliers. The company's reliance on a select group of suppliers for a significant portion of its imports necessitates robust contingency planning to mitigate potential disruptions. While specific details about backup suppliers are not publicly available, Opham's partnerships with multiple international laboratories suggest a degree of diversification in its supply chain. (opham.mg)

Importing Pharmaceuticals into Madagascar — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Madagascar

1Regulatory Authority & Framework

In Madagascar, the Direction de la Pharmacie et du Médicament (DPM) serves as the primary regulatory authority overseeing pharmaceutical imports and distribution. The DPM is responsible for ensuring the quality, safety, and efficacy of pharmaceutical products entering the country.

Key legislation governing pharmaceutical imports includes the Public Health Code, which outlines the requirements for drug registration, importation, and distribution. The marketing authorization pathway for Indian generics involves submitting a registration dossier to the DPM, including WHO-GMP certification, quality and efficacy data, stability studies, and labeling in compliance with national standards.

2Import Licensing & GMP

Import licensing requirements in Madagascar stipulate that only DPM-licensed importers and wholesalers are authorized to bring registered medicines into the country. Each shipment requires approved import authorization, customs clearance documentation, and verification of product registration status and quality certificates by the DPM.

Good Manufacturing Practice (GMP) certification is a critical component of the import process. The DPM recognizes GMP certifications from reputable authorities, including the World Health Organization (WHO), the European Union (EU), and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Indian exporters seeking to supply Opham must ensure their manufacturing facilities hold valid GMP certifications from these recognized bodies to meet regulatory standards.

Opham — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Opham's focus on importing advanced diabetes medications and CNS & psychiatric drugs aligns with the growing healthcare needs in Madagascar. The prevalence of diabetes and mental health conditions in the country drives demand for these specialized treatments. By concentrating on these therapeutic areas, Opham addresses critical health challenges and positions itself as a key supplier of essential medications.

The importation of Glibenclamide and Diazepam, which together account for 100% of Opham's top five imported products, underscores the company's strategic emphasis on these high-demand therapeutic categories. This targeted approach enables Opham to meet specific market needs effectively and maintain a competitive edge in the pharmaceutical distribution sector.

2Sourcing Profile

Opham's sourcing strategy is centered on importing generic drugs, primarily from India, to offer cost-effective solutions to the Malagasy market. The company's preference for finished pharmaceutical formulations, such as tablets, capsules, syrups, and injections, allows for efficient distribution and immediate availability to healthcare providers. India's robust pharmaceutical manufacturing sector, with its adherence to international quality standards, makes it a suitable partner for Opham's procurement needs.

This sourcing profile enables Opham to maintain a diverse product portfolio while managing costs effectively, ensuring that a wide range of essential medications is accessible to the Malagasy population.

Frequently Asked Questions — Opham

What products does Opham import from India?

Opham imports 2 pharmaceutical products across 2 categories. Top imports: Glibenclamide ($181.8K), Diazepam ($108.0K).

Who supplies pharmaceuticals to Opham from India?

Opham sources from 10 verified Indian suppliers. The primary supplier is Cipla Limited (37.9% of imports, $2.8M).

What is Opham's total pharmaceutical import value?

Opham's total pharmaceutical import value from India is $289.8K, based on 27 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Opham focus on?

Opham imports across 2 categories. The largest: Advanced Diabetes Medications (62.7%), CNS & Psychiatric (37.3%).

Get Full Opham Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Opham

Opham — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Opham?

What Formulations Does Opham Import?

What Products Does Opham Import?

Top Products by Import Value

Opham Therapeutic Categories — 2 Specializations